[178724586]
Age/date of birth: unknown/ not provided. Sex/gender: unknown/ not provided. Date of event: date unknown/ not provided if implanted; give date: healon is not an implantable device. If explanted; give date: healon is not an implantable device; therefore, not explanted. (b)(6). (b)(4). Correction/removal number: this complaint is part of the recall - report number 2020664-12/02/19-001-r: johnson & johnson surgical vision (jjsv) issued a voluntary recall on november 22, 2019. It has been reported customers have described healon gv pro as behaving differently than the legacy healon gv, especially in regard to the techniques required to remove the product from the eye. An increase of intra-ocular pressure (iop) is reported if there are small amounts of healon gv pro remaining behind the operative eye. This voluntary recall is being initiated due to received reports of healon gv pro being difficult to remove from the eye, leading to increased post-operative iop requiring additional intervention. Potential clogging of phacoemulsification equipment tubing has also been reported, which may lead to delay in the procedure or ocular injury. There are twenty-one affected lot numbers. The recall notification letter has been sent to all customers instructing them to return the units of healon gv pro from the twenty-one (21) affected lots. Johnson & johnson surgical vision has initiated a corrective and preventative actions (capa) to investigate and address the issue. Action items generated from the capa will be submitted in the future interim report(s) as part of the recall process. Attempts have been made to obtain missing information. However, to date, no response has been received. All pertinent information available to johnson and johnson surgical vision, inc. Has been submitted.
Patient Sequence No: 1, Text Type: N, H10
[178724587]
It was reported that during the injection of the healon gv pro, the surgeon noted the product was difficult to expel and that it clogged the hand piece. The surgeon reported of acute and chronic post operation hypertonia leading to abnormalities, postop refraction corneal burn, deformed pupil, intraocular pressure increases, lens dislocation, swelling of the capsular bag leading to post refraction anomalies, blindness in a case of glaucoma patient and hypertonia requiring an early yttrium-aluminum garnet (yag) treatments. Reportedly, about one hundred (100) patients are affected. Symptoms were treated. No additional information was provided. This report captures the event for the specific glaucoma patient, a separate report is being submitted for the about 100 patients reported. Additionally, the customer provided two different lot numbers. Due the limited information available to date, it was not possible to obtain the batch number related to this specific case. This report will address the batch number ue31283. A separate report will be submitted on the lot number ue31098.
Patient Sequence No: 1, Text Type: D, B5